Variant report
Variant | nsv437014 |
---|---|
Chromosome Location | chr6:133919776-133924082 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2636601 | chr6:133919776-133919777 | Weak transcription ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs114249852 | chr6:133919800-133919801 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529121049 | chr6:133919850-133919851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550474233 | chr6:133919855-133919856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143328309 | chr6:133919938-133919939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs59909010 | chr6:133919939-133919940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs200643031 | chr6:133919943-133919944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201959638 | chr6:133919944-133919945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs199705809 | chr6:133919945-133919946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs386706054 | chr6:133919947-133919948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144111964 | chr6:133920001-133920002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545864969 | chr6:133920160-133920161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562546686 | chr6:133920250-133920251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs368831288 | chr6:133920260-133920261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531559802 | chr6:133920314-133920315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543245538 | chr6:133920373-133920374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548513766 | chr6:133920386-133920387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568714172 | chr6:133920448-133920449 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527913440 | chr6:133920470-133920471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35418064 | chr6:133920472-133920473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs115142582 | chr6:133920525-133920526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570929323 | chr6:133920542-133920543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs149130243 | chr6:133920545-133920546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2677818 | chr6:133920563-133920564 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs568910004 | chr6:133920575-133920576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186963909 | chr6:133920621-133920622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs143296589 | chr6:133920656-133920657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541156171 | chr6:133920681-133920682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559215816 | chr6:133920690-133920691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2677819 | chr6:133920766-133920767 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs191384317 | chr6:133920851-133920852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2636600 | chr6:133920872-133920873 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs138843337 | chr6:133920891-133920892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142195803 | chr6:133920922-133920923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79162695 | chr6:133920967-133920968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181107357 | chr6:133920978-133920979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73773606 | chr6:133920995-133920996 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs561898723 | chr6:133921021-133921022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528008841 | chr6:133921047-133921048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs79753905 | chr6:133921101-133921102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2677820 | chr6:133921118-133921119 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs114870284 | chr6:133921120-133921121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185704475 | chr6:133921135-133921136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs73551412 | chr6:133921187-133921188 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs34863401 | chr6:133921297-133921298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376175191 | chr6:133921308-133921309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571836249 | chr6:133921313-133921314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537876225 | chr6:133921407-133921408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs138496403 | chr6:133921429-133921430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs386706055 | chr6:133921484-133921485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21785460 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:133912400-133925200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr6:133916000-133925200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr6:133917200-133925200 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
4 | chr6:133917400-133921600 | Weak transcription | Fetal Lung | lung |
5 | chr6:133919400-133919800 | ZNF genes & repeats | A549 | lung |
6 | chr6:133919800-133920400 | Weak transcription | A549 | lung |
7 | chr6:133920400-133920600 | Enhancers | A549 | lung |
8 | chr6:133921600-133922000 | Enhancers | Fetal Lung | lung |
9 | chr6:133922000-133922800 | Weak transcription | Fetal Lung | lung |
10 | chr6:133923800-133926600 | Weak transcription | Fetal Lung | lung |